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Abstract— Reconstruction of gene regulatory networks or 
'reverse-engineering' is a process of identifying gene interaction 
networks from experimental microarray gene expression profile 
through computation techniques. In this paper, we tried to 
reconstruct cancer-specific gene regulatory network using 
information theoretic approach - mutual information. The 
considered microarray data consists of large number of genes 
with 20 samples - 12 samples from colon cancer patient and 8 
from normal cell. The data has been preprocessed and 
normalized. A t-test statistics has been applied to filter 
differentially expressed genes. The interaction between filtered 
genes has been computed using mutual information and ten 
different networks has been constructed with varying number of 
interactions ranging from 30 to 500. We performed the 
topological analysis of the reconstructed network, revealing a 
large number of interactions in colon cancer. Finally, validation 
of the inferred results has been done with available biological 
databases and literature. 
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I. INTRODUCTION 
Cancer, medically known as a 'malignant', is a kind of 
disease involving unregulated cell growth. The cancerous cells 
are divided and grown uncontrollably forming malignant 
tumors and infest the nearby part of the body. The possible 
means to diagnose cancer are chemotherapy, radiotherapy and 
surgery but unfortunately, these methods of treatment often 
damage healthy cells and tissues. Therefore, identification of 
molecular markers of cancers may be an alternative approach 
to diagnose the human cancer and might be useful for 
development of novel therapies. Although, various significant 
genes responsible for the genesis of different tumors have 
been revealed but fundamental molecular interactions are still 
unclear and remains a challenge for the researchers. 
Due to rapid growth in microarray technology, gene 
expression of tens of thousands of genes can be measured 
simultaneously in a single experiment using a small amount of 
test sample that enable the researchers detect cancerous 
molecular markers [1]. Microarrays have been successfully 
used in many biomedical applications such as gene discovery, 
disease diagnosis, drug discovery and toxicology. A typical 
microarray gene expression data is a matrix R with N rows 
and M columns, where rows represent genes and column as 
samples (or environmental conditions or time-point). Due to 
experimental limitations, major problem with microarray data 
are dimensionality problem (M<<N) and presence of noise in 
expression values.  
Microarray-based cancer prediction is new and growing 
area of research. A gene regulatory network (GRN) tries to 
model the complex regulatory interactions within the living 
cells and give a realistic representation of gene regulation. The 
inference of GRN from microarray is referred as 'reverse-
engineering. Microarray gene expression profiles of whole 
genome can be used to understand cancer and to reconstruct 
cancer-specific GRN. The changes in expression profile of 
genes across various samples provide information  that can be 
used to filter differentially expressed genes between normal 
and tumor samples and helps to find regulatory relationships 
between gene-pairs which lead to the reconstruction of GRN. 
Mapping the topology of GRNs is a central issue in systems 
biology research [2]. Also, accurate computational methods to 
reconstruct genome-scale GRN from gene expression profiles 
are required to explore these experimental data in new and 
more integrative way.  
Many computational methods have been proposed in the 
literature to model GRNs including directed graph, Boolean 
networks, generalized Bayesian networks, linear and non-
linear ordinary differential equations (ODEs), machine 
learning approach, and so on. An extensive review can be 
found in [2, 3, 5, 6, 15]. Many others have tried to reconstruct 
cancer-specific GRNs using gene expression profiles [4][7]. In 
[4], a cancer-specific (prostate cancer) GRN has been 
reconstructed using Pearson's correlation coefficient (PCC) 
and a network of few most significant genes and their 
interactions has been identified. A comprehensive 
comparative evaluation of many state-of-the-art GRN 
inference methods has been done by Madhamshettiwar et. al. 
[7]. Finally best-performing method has been applied to infer 
GRN of ovarian cancer. Many other attempts has been made 
to reconstruct GRN of various cancers including colon cancer, 
ovarian cancer, lungs cancer and breast cancer.  
In this work, information theoretic approach called mutual 
information has been used to compute regulatory relationships 
between gene-pairs. We applied this approach to reconstruct 
GRN of colorectal cancer (CRC), the third leading cause of 
cancer mortality world-wide, which is a genetic disease, 
propagate by the acquisition of somantic alternations that 
influence the expression level of gene.  
II. MATERIALS AND METHODS 
In systems biology, many gene regulatory network (GRN) 
inference methods use information theoretic approach as an 
estimator to unveil the interaction and relations among genes 
in a cellular system from gene expression profiles. One of the 
initial method based on mutual information for GRN inference 
was introduced in [8]. This method, called relevance network 
(RN), assigns edges to gene pairs if the corresponding MI 
value is above a given threshold. The networks that result 
from application of RN are association networks because an 
edge between two genes indicates their association but not 
necessarily a causal effect. Another types of inference 
methods are also available that intend to find out causal 
interactions among genes and their products which can be 
validated with biological experiments, available databases and 
literatures. Till now, there is no generally agreed gold 
standard to conduct and include the routine of gene regulatory 
network inference and their analysis for molecular studies. 
However, essential preprocessing steps of the data are 
required to prepare them for the subsequent inference of a 
gene regulatory network involve standardized procedures for 
the normalization of gene expression distributions within and 
between samples and a summarization step to obtain gene-
centric values of the gene expression [9]. 
In this paper, we have applied mutual information to find 
the regulatory relationship between gene-pairs. 
A. Algorithm for the reconstruction of gene regulatory 
network 
The main steps for the reconstruction of gene regulatory 
networks are outlined as follows: 
(1) Data preprocessing and normalization. 
(2) Identification of significant genes. 
(2) Computation of MI among gene pairs. 
(3) Elimination of week correlation links. 
(4) Computation of adjacency matrix and network 
generation. 
(5) Biological validation of the results. 
(6) Druggability analysis 
 
An sketch of the proposed method is shown in Fig. 1. 
B. Identification of significant genes 
Before gene expression data is analyzed, first it is ensured 
data the data set includes genes that differ in their expression 
level significantly between two classes of samples. Many 
methods are available for identification of differentially 
expressed genes in the literature including fold-change, t-test 
statistics, ANOVA [10] rank product [11], Significant 
Analysis of Microarray (SAM) [14], Random Variance Model 
(RVM) [12], Limma [1], and so on. Due to wide applications 
and significant results of t-test statistics for samples having 
two different classes (e.g. cell types, cancer types, 
experimental conditions), we applied t-test to identify 
differentially expressed between the two classes normal and 
tumour. The t-test for unpaired data and both for equal and 
unequal variance  can be computed as [4],  
 
(1) 
 
where xi and yi are the means, gi and hi are the variances, and 
n1 and n2 are the sizes of the two groups of the sample 
(conditions) tumor and normal, respectively, of gene 
expression profile i. 
 
 
Fig. 1 Steps of the proposed methodology 
 
C. Estimation of Mutual Information 
The mutual information (MI), based on information theory, 
is a general measure for the nonlinear dependence of the two 
random variables. It is generalisation of pairwise correlation 
coefficient used to compare expression profiles of a set of 
microarrays and to measure the degree of independence 
between two genes. For each pair of genes, their MI(x,y) is 
computed and the edge axy=ayx is set to 0 or 1 depending on a 
significant threshold. Mutual information, MI(x,y), between 
gene x and gene y is computed as: 
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From the definition, the MI becomes zero if the two 
random variables x and y are statistically independent [that is, 
p(x,y)=p(x)p(y)], as their joint entropy H(x,y)= H(x)+H(y). A 
higher MI value specifies that the two genes are non-randomly 
connected to each other. The MI describes an undirected 
graph because it is symmetric, MI(x,y)=MI(y,x). MI is more 
generalized than the Pearson correlation coefficient (PCC) 
because it quantifies only linear dependencies between 
variables. However, MI and PCC yield almost identical results. 
According to the definition of MI,  it requires each samples 
(experiment) to be statistically independent from the others 
and thus this approach can deal with steady-state as well as 
with time-series gene expression data. 
III. RESULTS AND DISCUSSIONS 
In the present study we took the microarray data of 
circulating plasma RNA dataset of colorectal cancer (CRC) 
patient consisting of 20 samples collected from CRC patients. 
Out of 20 samples, 12 are from colon tumors and 8 are from 
normal biopsies. The dataset contains the expression profiles 
of 15552 genes obtained by measuring the relative abundance 
of the different RNA species in plasma through cDNA 
microarray hybridization, by comparing RNA isolation and 
amplified from colorectal cancer patients and from healthy 
donors. We downloaded the full data set from Gene 
Expression Omnibus (GEO) [13]. Fig. 2 shows the 
comparative view of gene expression of different samples for 
both colon cancer samples and normal samples. The 
expression of sample profiles in normal tissue is higher in 
comparison to that of cancer tissue in most of the cases. Many 
of the cancer sample profiles are down-regulated, as shown in 
Fig. 2.  
 
Fig. 2  Sample profile graph showing expression values in cancer and normal 
sample. 
Gene expression data contains a large number of genes, the 
majority of which may not be relevant for analysis. We 
applied t-test statistics to select most significant genes from 
the above dataset whose p-values are less than 0.01. We also 
eliminated those genes whose either gene name is not 
available or most of the values in expression profiles are 
missing. In this way, we found 101 most significant genes that 
have been selected for further analysis. To find the regulatory 
interactions among the selected significant genes, mutual 
information between gene pairs has been computed using 
equation (2). Now gene interaction network has been 
constructed, where nodes correspond to gene names and pair-
wise mutual information is allocated to the edge between 
genes. Initially, we took the top 30 highest pair-wise MI 
values (can be assumed as interaction weight) for the network 
construction and found a network of 22 genes, which is shown 
in Fig. 3. From the Fig. 3, it is clear that gene ACAT2 is 
highly connected with a degree of 9 and regulating a large 
number of genes. Similarly, we constructed nine other 
network by taking top 40, 50, 60, 70, 80, 90, 100, 250 and 500 
MI values and observed the five highly connected genes in 
each case. The observation of five highly connected genes in 
each of the network is shown in Table 1. From the Table 1, it 
is clear that as the number of interactions are increases, the 
degree of each hub genes are increases. The network 10 
considers 500 interactions that involves 79 genes, in which 
five highly connected genes are ACAT2(54), CYP1B1(50), 
NPM1(48), COX15(46), CREM(42), where numbers in 
parenthesis shows the connection degrees. The network 10 is 
shown in Fig. 4.  
Fig. 3 Network of 22 genes and 30 interactions 
 
 
 
Table 1. Ten different networks, number of genes involved in each, five 
highly connected genes with their degrees.   
    
Network No. No. of 
interac
tions 
Number 
of genes 
Top five genes with highest 
degree 
Network 1 30 22 ACAT2 (9), FABP5 (6), 
NPM1(6), COX15(5), 
CYP1B1(5) 
Network 2 40 25 ACAT2(9), FABP5(9), 
NPM1(8), CYP1B1(8), 
CREM(6) 
Network 3 50 27 ACAT2(12), NPM1(11), 
CYP1B1(10), FABP5(10), 
SNCA (7) 
Network 4 60 29 ACAT2(14), NPM1(13), 
CYP1B1(11), FABP5(10), 
SNCA(7) 
Network 5 70 30 ACAT2(14), NPM1(13), 
COX15(12), CYP1B1(12), 
FABP5(10) 
Network 6 80 31 CYP1B1(16), ACAT2(14), 
NPM1(13), COX15(12), 
SNCA(11) 
Network 7 90 35 ACAT2(17), CYP1B1(16), 
NPM1(14), SNCA(13), 
TNKS(13) 
Network 8 100 36 NPM1(18), ACAT2(17), 
CYP1B1(16), SNCA(13), 
TNKS(13) 
Network 9 250 56 CYP1B1(34), NPM1(33), 
COX15(30), ACAT2(30), 
CREM(28) 
Network 10 500 79 ACAT2(54), CYP1B1(50), 
NPM1(48), COX15(46), 
CREM(42) 
 
 
 
 
The identification of highly connected genes (hubs) may 
play a vital role in cancer diagnosis and therapies. The 
extracted genes has been validated with the available 
biological databases and literatures and found that most of the 
identified genes including ACP, LDHA, SPARCL, EPAS1, 
MVP, OXA1L, RPL10A, etc. are involved in colon cancer. 
All the identified interaction among genes including highly 
connected genes needs biological validation for its reliability. 
Further, the proposed method can be applied to benchmark as 
well simulated  dataset for its accuracy measure.  
IV. CONCLUSIONS 
Our study shows application of information theoretic 
approach to colon cancer, demonstrating how this approach 
can reveal novel gene regulatory interactions in case of cancer. 
We constructed ten different networks by varying the number 
of interactions ranging from 30 to 500, as shown in Table 1. 
The identified signature in first network captures the 
regulatory relationships among 22 differentially expressed 
genes. In case of tenth network considering 500 interactions, it 
shows regulatory relationships among 79 differentially 
expressed genes. Our study resulted three major outcomes. 
First, we identified differentially expressed genes in colon 
cancer patient, most of them are biological verified and found 
to participate in colon cancer. Second, the interactions 
between differentially expressed genes has been identified, 
which needs further biological validation. Third, we identified 
genes regulating most of the other genes (hubs). The utility of 
our approach and the reliability of the obtained results needs 
further experimental validation. These findings may help to 
reveal the common interaction mechanism of colon cancer and 
provide new insights into cancer diagnostic and therapy. 
Fig. 4 Network of 79 genes and 500 interactions 
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